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Abstract
Background: Telephone cognitive behavioural therapy (tCBT) is an acceptable and effective treatment for patients
with chronic widespread pain (CWP). Preventing the onset of CWP offers considerable benefits to the individual
and society and the MAmMOTH study is the first aimed at CWP prevention. The study is a two-arm randomised
trial testing a course of tCBT against usual care for prevention of CWP. This nested qualitative study explores
patients’ treatment experiences, with a view to understanding their potential influences on acceptability of the
intervention.
Methods: The MAmMOTH Study recruited 1002 participants, half of whom were randomised to receive tCBT.
Participants were eligible for invitation to the trial if they had pain for which they had consulted their GP, or had
pain and visited a doctor frequently, and had 2 of 3 risk factors for development of CWP. Participants randomised
to tCBT who had completed treatment were eligible for invitation to qualitative interviews for this study. Individual
qualitative interviews were conducted with a sub-sample (n = 33) of patients at high risk of developing CWP who
had been allocated to the intervention arm. Semi-structured telephone interviews explored treatment experiences
and intervention acceptability. Data was analysed using Framework analysis.
Results: Participants presented with a range of musculoskeletal and auto-immune conditions and almost half
described their pain as ‘chronic’ on study entry. Many participants perceived the trial intervention to be aimed at
treatment of pain rather than prevention of pain. Initial expectations prior to treatment varied, with scepticism
more likely for those who had little prior knowledge of CBT approaches. All participants provided positive feedback
post intervention particularly in relation to the modality, therapist experience and skills and the intervention. The
majority of participants described positive changes in either their subjective level of pain or pain-management
post-intervention and some attributed the positive change directly to the intervention as a result of empowerment,
increased self-management and cognitive restructuring.
Conclusions: This study extends our understanding of the acceptability and suitability of preventative interventions
for chronic widespread pain and provides further evidence for the acceptability of tCBT.
Trial registration: Clinical Trials.gov NCT02668003 (registered 29th January, 2016).
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Background
There is increasing evidence that psychological therapy
delivered by telephone is accessible and effective for a
range of conditions and it offers particular advantages by
allowing those with disabilities, childcare and employ-
ment commitments and geographically remote patients
to access health services without the need for scheduled
face-to-face appointments [1, 2].
With regard to cognitive behavioural therapy (CBT) in
particular, evidence suggests that CBT delivered by tele-
phone is superior to ‘treatment as usual’ for a number of
conditions [3], and the recent MUSICIAN study has
demonstrated treatment efficacy, cost effectiveness and
acceptability for patients with Chronic Widespread Pain
(CWP) [4–6].
CWP has been defined as pain lasting longer than 3
months which affects both sides of the body, above and
below the waist; it is often associated with fatigue and psy-
chological distress [7, 8]. CWP affects between 11 and
16% of the population [9] and results in considerable costs
to the individual and society [10]. Usual care for CWP is
based on treatment guidelines which recommend pharma-
cological, physical and psychological interventions [11]. A
multidisciplinary approach is often taken incorporating
education about the condition alongside graded exercise,
pacing activities, drug therapy, psychotherapeutic inter-
ventions and sleep management [12]. Evidence suggests
that early intervention and improved prognostic indicators
for musculoskeletal pain might be particularly effective
since longer duration of symptoms (> 6months) is linked
to poorer outcomes [13, 14].
Moving beyond management to prevention of CWP is
thus clearly desirable and now possible due to the avail-
ability of prediction models which can identify those at
high risk of developing CWP. The Maintaining Muscu-
loskeletal Health (MAmMOTH) study [15] is testing the
hypothesis that among patients who are identified as at
high-risk, a short course of telephone-delivered CBT
(tCBT) can prevent the development of CWP when
compared to usual care. This is the first randomised
controlled trial (RCT) aimed at CWP prevention.
Successfully implementing research into NHS practice
requires that new interventions are accepted and wel-
comed by those receiving the service. The acceptability
of an intervention involves making a normative judge-
ment based on the extent to which it can be tolerated
and considered reasonable [9]; acceptability is likely to
be a multi-faceted construct involving cognitive and
emotional responses [16]. Qualitative methods are there-
fore the most appropriate method to explore these views
as they offer the opportunity to examine what really
matters to patients and what might facilitate and hinder
an intervention [17] and have been used successfully in
other studies exploring the management of CWP [6].
This paper reports the findings of a qualitative study
nested within the MAmMOTH RCT, conducted with a
sub-sample of participants in the intervention arm who
received tCBT. The study aimed to explore participants’
treatment experiences with a view to understanding
their potential influences on intervention acceptability.
A behavioural approach to the management of chronic
pain is well established as being effective and cost effect-
ive and we have moved to using this approach in per-
sons who have symptoms which put them at high risk.
Whether this particular trial is effective or cost effective
we would argue that a behavioural approach to the
symptoms marking people as at high risk is very relevant
and thus establishing the acceptability is important. In
the event that this approach is not (cost) effective under-
standing issues of acceptability will be relevant for future
studies and service delivery. Indeed we think there are
some advantages in evaluating the acceptability of an
intervention before the main trial results are known – in
that interpretation is not influenced by this knowledge.
Therefore, the acceptability study has been intentionally
conducted and analysed before trial outcomes are known
to avoid biased interpretation [18].
Methods
Potential participants for the MAmMOTH RCT were
identified via primary care screening questionnaires dis-
tributed to persons registered at selected GP practices
within three Scottish Health boards. Patients were eli-
gible if they were identified as being at high risk of de-
veloping CWP, determined by the presence of pain for
which they had consulted their GP in the previous 6
months, along with 2 out of 3 of the following indica-
tors: high illness behaviour score; high number of som-
atic symptoms; high sleep problem score.
The telephone CBT intervention (tCBT), delivered to
those patients randomised to the intervention arm, con-
sisted of an initial assessment session (45–60 min), 6
weekly sessions (each 30–45min) delivered over a six
week period and follow up ‘booster’ sessions at 3 and 6
months. The sessions involved education (e.g., about
musculoskeletal pain and somatic symptoms) and spe-
cific CBT techniques (e.g., behavioural activation, activ-
ity pacing and identifying and challenging negative and
unhelpful thinking patterns). Participants were also sup-
ported via a self-management CBT manual [19] to facili-
tate collaborative goal setting between therapist and
patient, diary keeping and exercises to complete after
specific sessions. Full details of the trial can be found in
the published protocol [15].
The intervention was delivered by BABCP (British As-
sociation for Behaviour and Cognitive Psychotherapies)
accredited CBT therapists with at least two years’ experi-
ence of delivering CBT. All therapists attended a
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two-day training course on the intervention prior to
treatment delivery and received two-weekly supervision
from trained and experienced CBT therapists.
Participants were eligible for invitation to the qualita-
tive study if they had completed at least one treatment
session and had not been withdrawn from treatment.
Participation in the nested qualitative study was volun-
tary and not a pre-requisite for trial participation. Invita-
tions were sent by letter 12 months post treatment start
by the study coordinator to 101 participants. The ration-
ale for inviting 101 was to ensure a sample of around 30
participants could be achieved as this was considered
necessary to achieve data saturation [20, 21]. A 30% re-
sponse rate was considered to be a reasonable estimate
to a follow up postal invitation based on the trial team’s
experience and other published data [22]. Sampling was
purposeful in that we targeted participants who had ex-
perience of the trial intervention. Variation in geograph-
ical location was achieved by sampling across all three
trial recruitment sites. All invited participants who
expressed an interest in the qualitative study were re-
quested to return a consent to contact form (n = 39); on
receipt participants were telephoned to provide further
information about the study and to discuss participation.
The MAmMOTH trial adheres to CONSORT guidelines
and in line with such reporting the participant flow from
the trial to this nested study is included in the Partici-
pant Flow diagram (see Additional file 1).
Semi-structured in-depth telephone interviews were
conducted to determine participants’ perspectives on
treatment experiences and acceptability. The interview
schedule (see Additional file 2), was drafted by CF based
on previous qualitative work by members of the team
[10] and reviewed by all authors and a patient represen-
tative prior to ethics submission. The schedule was orga-
nised around three broad topics: context (extent of
current difficulties; reasons for participating in the trial);
process (expectations and experiences of receiving the
intervention; reflections on mode of treatment delivery);
outcome (perceived impact of intervention and treat-
ment acceptability). Interviews were conducted by tele-
phone on a pre-arranged date and time (between
December 2017 and March 2018), consistent with the
treatment delivery approach. All interviewees took part
in one telephone interview conducted at least 12 months
after the start of treatment. The rationale for this was we
wanted to complete collection of the main outcome be-
fore doing the interviews. If we had done interviews be-
fore collecting the 12-month outcome we would be
measuring the effect of having the intervention and the
interview – it’s possible an opportunity to give feedback
about the intervention could change the way participants
answered the questionnaire. It’s also possible that partic-
ipants would be less likely to provide the main outcome
if they had just been invited for interview because of ‘re-
search fatigue’. All interviews were conducted by an
experienced qualitative researcher (CF) who was inde-
pendent from the main trial study team and not previ-
ously known to participants. Interviews were digitally
recorded with the consent of the interviewee and tran-
scribed verbatim. Interview duration ranged from 15 to
57min; mean (SD) 25.4 (9.1) minutes. Demographic and
intervention sessional data was provided by the study
coordinator after the interviews were completed.
Data analysis was completed using Framework analysis
[23]. Transcripts were read independently by CF and, to
enhance the rigour of the study, another member of the
research team (KL) to achieve familiarisation with the
data and to check data saturation had been reached in
line with the study’s aims and objectives. This combined
reading of the transcripts by two researchers also facili-
tated discussion of the emerging themes which were
then used to develop a theoretical framework.
Each transcript was then then analysed in detail by CF
by indexing data into the theoretical framework in
Microsoft Excel using a matrix approach with partici-
pants represented as rows and themes represented as
columns. During the indexing and subsequent charting
process the theoretical framework was revised and re-
fined, for example to capture any newly emerging
themes and to merge overlapping themes. The final ver-
sion of the theoretical framework was agreed by all au-
thors and is supplied as an additional file to this
manuscript (see Additional file 3). After consensus on
the theoretical framework was reached, the first author
re-read all the transcripts to check ‘fit’ with the frame-
work and drafted the paper. All authors commented on
drafts of the findings to produce the final manuscript.
Results
Of the thirty-nine patients returning consent to contact
forms, thirty-three went on to participate in telephone
interviews. Two patients declined to participate after be-
ing contacted by the researcher due to lack of time, two
did not respond to attempts to contact and two were
not contactable due to incorrect or incomplete contact
details provided.
All thirty-three participants had completed the inter-
vention initial assessment and all but one had gone on
to receive tCBT treatment and follow up sessions. One
participant who had only completed the initial assess-
ment was invited to the acceptability study in error and
this participant’s data is not included in the analysis pre-
sented in this paper. For the thirty-two patients who
went on to access tCBT, the number of treatment ses-
sions completed ranged from 4 to 6; the number of fol-
low up sessions completed ranged from 1 to 2.
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The nested sample was largely representative of the
trial population in respect of age and gender; interview
participants scored slightly poorer on all baseline mea-
sures of health (Table 1).
Three main themes emerged from the data: i) Pre-
senting issues and pain management, i.e., the type of
pain experienced and help received prior to the trial;
ii) Expectations and reflections, which describes trial
perceptions and participants’ motivation to partici-
pate and reflections on receiving the intervention
and iii) intervention impact and acceptability, refer-
ring to the perceived impact of the intervention and
acceptability.
Presenting issues and pain management
The first theme, entitled presenting issues and pain
management describes the issues which participants
presented with at the start of the trial including the
nature of pain experienced, pain management strat-
egies employed and help received prior to participat-
ing in the trial.
Nature of the pain experienced
As might be expected given the focus of the trial,
interview participants experienced a range of issues
related to musculoskeletal as well as auto-immune
conditions as detailed in Table 2. Almost half of those
interviewed described their level of pain on entering
the study as ‘chronic’ or ‘debilitating’ resulting in sig-
nificant disruption to their daily lives, particularly in
relation to sleep, mobility, mental health and general
well-being:
“I’d been having a lot of pain … it was debilitating
and exhausting and because I’m a very busy person,
it stopped me from doing things that I basically love
doing ….” (IV3).
Pain management strategies employed
A small number of participants had already adopted
their own discomfort and pain self-management strat-
egies, for example, positive thinking, exercising, pacing
or resting prior to involvement in the trial and these
were used by them to minimise the impact of the pain
experienced:
“Well, I was taking exercise, going out for a walk, and
it seemed to help. I stopped taking the tablets before
the course started and it was just positive thinking,
ignoring the pain, and it was fine ….” (IV2).
Help received prior to participating in the trial
The participants interviewed had experienced a wide
range of medical and physical interventions prior to trial
recruitment. More than half of those interviewed were
taking regular medication including analgesics and
anti-inflammatory drugs and about a quarter had been
referred by their GP for further consultations and/or
treatment (including steroid injections and operative
treatments). Two thirds of the sample had received man-
ual physical therapy, the majority via NHS physiotherapy
services, whilst some had accessed a range of private al-
ternative treatments including osteopathy, hypnotherapy,
acupuncture and chiropractic treatments. Other pain
management strategies employed included exercise,
cryotherapy and heat treatment.
Expectations and reflections
The second theme to emerge from the data, expecta-
tions and reflections, comprised of three main
sub-themes: Trial perceptions and motivation to partici-
pate, initial expectations prior to therapy and reflections
on receiving the intervention.
Table 1 Baseline characteristics for the trial sample and nested qualitative study
Total Trial sample (n = 1002)
Trial participants not interviewed (n = 970) Nested qualitative study participants (n = 32) Difference (95% CI)
Age, years, mean (SD) 57.7 (14.4) 61.4 (12.8) 3.8 (−1.3–8.8)
Female, n (%) 570 (58.8) 19 (59.4) 0.6% (−1.7–1.8%)
Illness Behaviour, mean (SD) 9.8 (3.5) 10.3 (3.2) 0.5 (−0.8–1.7)
Somatic symptoms, any, n (%) 451 (46.5) 16 (50.0) 3.5% (−1.4–2.1%)
Sleep problems score, mean (SD) 10.2 (4.6) 10.2 (4.5) 0.0 (−1.6–1.7)
EQ 5D, mean (SD) 0.70 (0.19) 0.67 (0.11) −0.03 (− 0.09–0.04)
ICECAP, mean (SD) 0.85 (0.15) 0.83 (0.13) −0.02 (− 0.08–0.03)
GHQ, > = 2, n (%) 431 (44.9) 15 (46.9) 2.0% (− 15.6–20.0%)
Polysymptomatic distress, mean (SD) 7.1 (3.5) 8.2 (2.8) 1.0 (− 0.2–2.3)
CI confidence interval, SD standard deviation, IQR inter-quartile range
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Trial perceptions and motivation to participate
Although this was a prevention trial, targeting partici-
pants at risk of developing CWP, it seemed that for some
participants, the MAmMOTH study was perceived to be
a trial focused on managing (rather than preventing)
CWP. Although many were motivated to take part as
they wanted to support health research, some were sur-
prised to meet the inclusion criteria as they only experi-
enced ‘discomfort’ or ‘irritating’ or ‘not bad pain’:
“… I was surprised I was even chosen for this study, to
be honest … I didn’t think my pain level would have
justified being part of this study, because I had such
small niggling pains...” (IV7).
However, for those participants who described experi-
encing more ‘chronic’ pain, the trial was a welcome op-
portunity to try a new way of working with their pain.
Some patients appeared to have assessed the potential
for gain versus risk when considering whether to partici-
pate in the study and judged it to be a non-invasive, low
risk, ‘nothing to lose’ opportunity and an alternative to
medication:
“I didn’t think I’d anything to lose. It wasn’t going to
make my condition worse. You know, it wasn’t like I
was trying a new exercise or a physical exercise that
would make the pain worse, so I thought, well let’s just
go for this.” (IV22).
Others highlighted the contrast between the trial inter-
vention and usual GP care, highlighting that taking part was
an opportunity to be listened to, to be given time to talk:
“I feel that I can probably get more from [the trial]
talking about this, than I can, like I could a doctor,
because he doesn’t have the time … you are very
conscious of how stretched they are these days I think.
You are. I mean all you have to do is look in the
waiting room, don’t you?” (IV6).
Initial expectations prior to therapy
Prior to the first session about a third of participants
had fairly low expectations about what the intervention
could achieve for them, either due to scepticism about
how talking could impact on a physical symptom or be-
cause they had doubts about the relevance of this ap-
proach for their particular condition:
“I was very sceptical about it initially because I
thought, how can this help me?...the way we were trained
as nurses, that we must observe the patient, observe
people face to face … I never thought that I could ever re-
spond to a phone call … If you can’t see somebody, how
could this work?” (IV3).
Some participants described themselves as ‘open--
minded’ and ‘willing to give it a try’; whilst others said
they really didn’t know what to expect but were curious
enough to engage with the intervention.
Table 2 Sample Demographics






IV1 51 F Lower back pain, neck pain
and migraines
IV2 67 M Back and leg pain
IV3 77 F Osteoarthritis
IV4 54 M Sciatic pain (trapped nerve)
IV5 64 M Musculoskeletal injuries
(shoulder, knee, hip)
IV6 74 F Musculoskeletal injury (knee)
and frozen shoulder
IV7 49 F Patella femoral joint syndrome
IV8 74 F Knee pain
IV9 79 F Osteoarthritis
IV11 47 F Musculoskeletal injury (back)
IV12 48 M Musculoskeletal injury (knees)
IV13 67 F Rheumatoid Arthritis
IV14 50 M Musculoskeletal injury
(shoulder)
IV15 68 F Ankylosing spondylitis
IV16 63 M Osteoarthritis
IV17 56 F Multiple sclerosis
IV18 69 M Osteoarthritis
IV19 53 M Sinus pain and migraines
IV20 64 M Arthritis (knees)
IV21 86 F Arthritis (knees and hands)
IV22 47 F Back pain
IV23 41 F Musculoskeletal injury (back,
neck and shoulder)
IV24 48 F Neck and shoulder pain
IV25 35 F Migraines and tendonitis
(foot)
IV26 62 M Sciatica (slipped disc and
trapped nerve)
IV27 46 M Inflammatory bowel disease
IV28 72 M Muscle cramps/leg pain
(Parkinson’s)
IV29 70 F Osteoporosis and Urinary
Tract Infection
IV30 64 F Sciatica
IV31 54 F Inflammatory pain (Lupus)
IV32 78 M Knee pain
IV33 75 F Osteoarthritis
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About a fifth of participants had a good understanding
of cognitive behavioural approaches and began the trial
with high expectations about the benefits of talking ther-
apy in relation to pain management, either based on
prior experience of CBT (for other health conditions) or
from their own reading or professional roles.
Reflections on receiving the intervention
When participants were asked to reflect on the interven-
tion the majority were very positive and their feedback
highlights key factors in relation to intervention modal-
ity, the therapists delivering the intervention and the ac-
companying intervention manual.
Commenting on the intervention modality, more than
two thirds were completely satisfied with receiving this
type of intervention by telephone and saw no additional
benefits to be gained by receiving the intervention
face-to-face. Indeed many were keen to highlight a range
of benefits to be achieved via this modality, for example,
confidentiality, anonymity and reduced stigma.
The telephone-based intervention also increased ac-
cessibility for those who were working and/or had child-
care commitments and those who were geographically
remote from NHS clinic sites.
Some participants had mixed views on modality: whilst
recognising some of the benefits (as highlighted above)
that telephone interventions can offer, they wondered
whether face-to-face support would achieve a more per-
sonal and holistic approach and enhance the therapeutic
process, for example, by incorporating non-verbal com-
munication. Two participants felt the telephone did not
afford a sufficiently in-depth approach as compared to a
face to face approach:
“… I don’t think it would really be a long-term answer,
but it’s certainly helpful in the interim, yes … it’s really
because you can’t actually see someone and you’re not
sitting in the same room as someone. There’s nothing
beats personal contact and a conversation over the
phone is certainly an awful lot better than no conver-
sation at all … but, yeah, a little bit of personal con-
tact would be more advantageous, I think.”(IV5).
Interviewees commented warmly on the therapists de-
livering the sessions, describing them as experienced and
skilled professionals who were friendly, knowledgeable,
empathic and able to quickly establish rapport and put cli-
ents at ease. Participants also welcomed the consistency,
reliability and convenience of speaking to the same
therapist at each session and that times were arranged
to suit the needs of the participant. This availability
of the therapist was further enhanced by the thera-
pists’ skills in reflecting key details from previous ses-
sions to offer an individualised approach.
For those who had no prior experience of therapeutic
support, this down to earth and personalised approach
was a welcome contrast to what they had been
expecting:
“She was brilliant. She was just really nice, just really
… really nice, really normal. I was a bit concerned it
might be a bit airy-fairy and a bit too, you know,
psycho-analytic type thing; but no, it wasn’t like that
at all.” (IV11).
All participants confirmed they had received the ac-
companying self-management CBT manual and about
two thirds reported using it. Many positive aspects of
the manual were identified relating to the content, struc-
ture and purpose. For example, participants used the
manual as an aide memoire between sessions, to recall
sessional advice and to prompt and motivate their daily
goals. Notes could also be made for topics to be dis-
cussed with the therapist at the next session which could
help participants to articulate their thoughts.
The manual was also important for some in helping to
foster the connection between mind and body and prin-
ciples of CBT and in enhancing their understanding of
pain triggers in order to identify solutions. For those
who already had a reasonable understanding of the
mind-body link and CBT approaches, the manual offered
reassurance that they were adopting the correct tech-
niques and helped them feel less isolated in their
experience:
“There was a lot of statements in there which you
begin to realise, yes, that’s true, I know about that.
What it does is, first of all, it assures you that your
circumstances are not unique, and that what you’re
experiencing is not the worst thing ever in the world
because other people are experiencing it as well …
what’s happening to you is happening to other people
as well, and that’s rather comforting.” (IV5).
In suggesting ideas to improve the manual some had
found it ‘difficult to navigate’ and others ‘repetitive’ or
‘too rigid’ – which was contrasted with the personalised
and adaptable approach of the therapist. Some would
have liked more information at the outset about the pur-
pose of the manual alongside the therapeutic sessions
and how this would be used by the therapist and client
throughout the intervention. Ultimately though, what
was important was that the manual was offered along-
side the therapeutic support of the therapist:
“You look at it initially and you think, is this really
going to work? But actually for me, what made it work
was [therapist]. If you had given me the booklet on my
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own and had said, right you go away and study that
and you give it a go, no it wouldn’t have worked. That
would have probably turned me off quite quickly.
Having [therapist] there though and being able to
speak with him and him explaining how it works and
what I needed to do and us then sitting down the
following week and discussing things … having his
backup and his kind of understanding was without a
shadow of a doubt what helped it along.” (IV24).
Intervention impact and acceptability
The third and final theme, intervention impact and ac-
ceptability, describes post-intervention changes reported
by participants and intervention acceptability.
Post-intervention changes reported by participants
The majority of participants described positive changes
in either their subjective level of pain or their
pain-management post-intervention and many attributed
the positive change directly to the telephone support
intervention. Six participants attributed positive change
to something other than the intervention and two felt
they had improved due to a combination of the tele-
phone intervention plus something else such as tele-
phone therapy plus acupuncture or medication.
For the participants reporting positive changes dir-
ectly attributed to the intervention, nine of these re-
ported lower or more manageable levels of pain
which seemed to relate to an increase in
self-awareness and self-management of symptoms and
evidence of cognitive re-structuring.
“What was interesting is how those sessions got me to
think...well, I suppose, basically, sort of, empowered me
by showing me how to gain control over what actually
what is the reality, what was going on in my head and
what I was actually physically experiencing, and I
realised that the pain wasn’t that disabling and not
that often, it was the thought of it I suppose and the
depressing thought of it and, yes, when the pain’s bad
it is very bad but then I saw that...I saw a pattern. I
started to see things that were causing it.” (IV1).
“It’s definitely better now than it was when I
started. I still get little moments of it, but it’s not
impacting on my daily life at all. Not stopping me
doing anything … I think there is a move in
attitude for me. I think I’m less anxious and less
worried about it than I was … I think having
worked through it with everything that research
programme and everything that went round it, you
know that if you get it back, you know it can be
worked through again and go away..” (IV30).
Participants also valued having someone to share their
experience with, without which, the pain could have
been an isolating experience:
“I felt quite good talking about it to be quite frank
with you, you know? I’ve got nobody else to speak to
about it, and I certainly never tell my family. You
know, I keep my pain to myself. Who wants to sit and
listen to people moaning, you know? Nobody. But
that’s why I really enjoyed talking to [therapist], ‘cause
I could explain it all better to her you know, the type
of thing I was suffering.” (IV21).
For the remainder of the participants reporting posi-
tive changes directly attributed to the telephone inter-
vention their pain was still present but they had changed
the way they thought about their pain and were now
able to “put things in perspective”, “think of others
worse off” or to focus less on the pain:
“I’d definitely say it helped. The pain I wouldn’t say
went away, but probably I wasn’t as focused on it. I
didn’t get as grumpy about it; I didn’t get into a
mindset of blaming it for why I couldn’t exercise, why I
was feeling low, getting irritable, all these sorts of
things. That probably was a help.” (IV14).
Understanding the link between stress and pain was a
key strategy and had resulted in the adoption of more
realistic goals and increased self-management. Some par-
ticipants talked of re-focusing, of understanding their
pain more, and feeling more confident to move, being
more active and less passive, particularly via the use of
goal setting strategies and modifications.
“I’ve very much learnt … like, I take things in small
chunks, and I will rest when I need to rest, and
therefore I can do more; and it’s really about
managing it and, kind of, understanding myself when
I’m starting to struggle; because I’m really bad for
pushing through and just trying to keep going.” (IV11).
For the six participants who attributed their reduced
or more manageable levels of pain to something other
than the trial intervention the reasons cited included
medical (receiving an alternative diagnosis; change in
medication; access to new medical treatments); physical
(physiotherapy; working less hours; reduction in exercise
regime; acupuncture) and psychological (adopting a
more positive attitude) interventions outside of the trial
treatment.
Four participants who felt there had been no changes
post-intervention were still positive about the potential
benefits for others from the intervention. In one case
Fraser et al. BMC Musculoskeletal Disorders          (2019) 20:198 Page 7 of 11
the trial was felt to be unsuitable as the participant did
not consider their main source of pain to be musculo-
skeletal although they did have a diagnosis of osteopor-
osis; in three other cases the intervention was
considered to have effected little or no change as the
participants were already using cognitive and pain man-
agement strategies prior to being recruited into the trial.
Thus, whilst the trial intervention appeared to be less
suitable for a small number of participants, it was clear
that all found this type of intervention acceptable in
principle and all thirty-two participants said they would
recommend the intervention to a friend or family mem-
ber in similar need.
Based on the feedback in this study about wider ac-
ceptability some caveats on intervention acceptability
and suitability were suggested by participants which
might be considered prior to any intervention roll-out –
these external factors, and how best to overcome them,
as suggested by participants, are summarised in Table 3
below:
Discussion
The present study sought to explore patients’ experi-
ences of tCBT to prevent chronic widespread pain with
a view to understanding their potential influences on
treatment acceptability. Interviews were undertaken with
research trial participants allocated to the intervention
arm in a two-arm randomised trial testing a course of
tCBT against usual care for CWP.
Our data suggests that a tCBT intervention is ac-
ceptable and can have a positive impact based on pa-
tients’ subjective qualitative assessments of changes
post-intervention. This is particularly important since
almost half the sample described their pain as chronic
or debilitating prior to receiving the intervention and
were accessing a vast range of NHS and alternative
provision treatments.
This reported impact is of particular note given the
initially sceptical mind-set of about a third of the sample
prior to participating in the trial. Whilst many were
“desperate for help” and “willing to try anything” some
were unsure of the link between mind and pain or
doubted that the intervention would have any personal
benefits. This finding is consistent with other research
exploring acceptability of a CBT intervention for (orofa-
cial) pain which found barriers to engagement could in-
clude participants initially considering the intervention
to be not appropriate for them, for example due to asso-
ciations between CBT and depression [24]. In that study,
as with the present study the belief that the study could
help others could overcome this scepticism, thus dis-
playing perhaps, evidence of unconditional altruism [25].
As the intervention in this study was delivered in the
context of a trial the screening process did not include
sharing information with potential participants that a
treatment aimed at altering thoughts and behaviours
might be effective for symptoms. Consistent with other
research, participants in this study appeared to have
assessed the potential for gain versus risk when consid-
ering whether to participate in the study [10].
When asked to reflect back on their experiences of the
intervention the majority of the participants were keen
to praise the intervention and its perceived impact dem-
onstrating a significant cognitive shift for some. Patients
were on the whole satisfied with the intervention modal-
ity (telephone), the therapists, and the accompanying
manual although a small proportion would have pre-
ferred face to face support. The data also suggests that
for many there had been positive changes, either a re-
duction in pain or a revised attitude towards the pain
which made it more manageable. Whilst some linked
this change to the wider range of interventions received
(including medication and physical therapy), two thirds
of those interviewed attributed the change directly to
the telephone intervention received. Our findings were
Table 3 External factors which might influence intervention acceptability and suitability
Factors affecting intervention acceptance Methods to address these factors
Scepticism and resistance Clear information at screening about the nature and style of the
intervention (cognitive behavioural therapy) and about the link
between what we do, the way we think and our physical symptomsSome will be sceptical and resistant to the idea of a ‘counselling’
approach to preventing chronic widespread pain
Timing Intervention impact may be increased if offered earlier rather than
later, for example, when participants are experiencing low to
moderate pain.Timing of the intervention offer could impact on acceptability and
suitability
Baseline Knowledge Intervention screening should include assessment of baseline
knowledge and existing use of self-help and CBT pain management
techniquesIntervention most useful for those with little or no prior experience
of CBT pain management techniques
Presenting Symptoms Intervention screening should include assessment of symptoms
experienced. Intervention is likely to be most helpful for those with
Musculoskeletal pain.The presenting symptoms experienced may impact on acceptability
and suitability
Fraser et al. BMC Musculoskeletal Disorders          (2019) 20:198 Page 8 of 11
consistent with earlier acceptability studies which have
found positive appraisals of CBT interventions for pain
despite some initial scepticism or pre-conceived ideas
about CBT being a psychological treatment [10].
A particularly interesting finding to emerge from the
interviews was some participants’ interpretation of this
being a study about the treatment of existing pain rather
than about preventing the onset of chronic widespread
pain. This was somewhat unexpected given the screen-
ing criteria and overall trial aims. It is possible that these
participants saw the intervention as managing their
CWP which they experience intermittently and indeed
this type of intervention has been used to manage CWP.
We do not feel that this makes the intervention any less
appropriate. In addition, the acceptability study sample
did have more pain prior to recruitment, as indicated by
the number of pain sites identified in a baseline screen-
ing questionnaire – a median of 6 in those interviewed
(IQR 3–7.5) compared to 4 in the rest of participants
(IQR 3–6). So those interviewed were perhaps less likely
to view the study as a preventative trial due to their
existing levels of pain.
This study adds to the literature by extending our un-
derstanding of the acceptability of interventions for
chronic widespread pain in a preventative rather than a
treatment setting and adds to the wider research litera-
ture on the suitability of psychosocial interventions for
patients experiencing pain [10, 24].
Study limitations
The views expressed in this qualitative study are those of
a sample (11%) of the trial cohort who completed at
least one treatment session when invitations to the ac-
ceptability study were sent and who had not formally
withdrawn from treatment or trial without mutual
agreement of the therapist (n = 302). Those who did for-
mally withdraw (n = 172) or had not completed at least
one treatment session (n = 27) may have found the inter-
vention less acceptable. However, we know from the
earlier MUSICIAN study [4, 26] that around 1 in 3
people randomised to studies of the management of
chronic widespread pain will not engage with CBT. The
current study is a prevention study and so it is not sur-
prising that the engagement is less since a) people might
see less relevance in a prevention study and b) the iden-
tification of people at high risk will have identified some
people who are not at high risk of developing CWP
(since high risk is defined on a group basis). So to have
60% of people engaging in such a prevention study is
very positive and is in line with the assumptions made
prior to the trial getting underway. It could also be ar-
gued that any sample in a trial cohort is to an extent
skewed since by agreeing to be randomised to a tCBT
trial they are likely at the outset to find the intervention
somewhat acceptable. In addition, the cross-sectional
nature of the study means that data was only collected
at one point in time after follow up and further longitu-
dinal studies will be needed to ascertain if the type of
gains noted can be sustained in the longer term after
this type of intervention.
However, these limitations should not detract from
the importance of incorporating nested qualitative
studies within trials as they afford participants the op-
portunity to raise issues not otherwise captured as
highlighted in feedback from two participants in this
acceptability study about the limitations of the main
trial outcome measures in capturing their treatment
gains.
A future study might seek to also incorporate the
views of the therapists delivering the intervention, par-
ticularly given the observation that this was largely
viewed as a pain rather than prevention trial. Incorporat-
ing the therapists’ views in this study would have
allowed a deeper exploration of this interpretation and
how it may have impacted on treatment impact and
acceptability.
Conclusions
This study extends our understanding of the acceptabil-
ity and suitability of preventative interventions for
chronic widespread pain and provides information on
aspects which may be modified in the future to further
enhance treatment acceptability and effectiveness.
Our analysis revealed that participants that completed
treatment may have initially either self-managed or
adopted a range of other options for pain management
prior to starting tCBT. Although they may have thought
themselves unsuitable for this type of treatment, or
thought that it might be ineffective, they were willing to
engage based on the novelty and low-risk. While they
may have initially had low expectations for treatment ef-
fectiveness, they found their experience was positive,
highlighting the treatment modality, qualities of the
therapist and the level of contact compared to other ex-
perience of health care. Those experiencing a positive ef-
fect of the treatment did so through changes in attitude.
Steps were identified that could improve acceptability of
treatment for participants including assessing prior
knowledge of this treatment and giving information
about it at screening.
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